MAY 1.0 2002
Attachment 6 K OA0DYS 3 (PR
__—
510(K) Summary of Safety and Effectiveness
This 510(K) Summary of Safety and Effectiveness for the Palomar Estel.ux™ Pulsed
Light System is submitted in accordance with the requirements of Safe Medical Device
Act (SMDA) of 1990 and follows the Office of Device Evaluation (ODE) guidance
concerning the organization and content of a 510(K) summary.
Applicant: Palomar Medical Technologies, Inc.
Address: 82 Cambridge St.
Burlington, MA 01803
781-993-2300
Contact Person: Marcy Moore
Telephone: 919-363-2432
. Preparation Date: February 6, 2002
Device Trade Name: Palomar EsteLux™
and Coo\Roller™
Common Name: EsteLux™, CoolRoller™
Classification Name: Laser surgical instrument for use in General and
Plastic Surgery and in Dermatology
(see: 21 CFR 878-4810).
Product Code: GEX
Panel: 79
Legally-Marketed Predicate Device: ESC IPL Quantum HR; K991935
Laserscope CoolSpot™; K984110
System Description:
The EsteLux™ is a light-based medical device
designed for permanent hair reduction, effective
removal of unwanted hair, treatment of facial and
leg veins, and treatment of pigmented lesions in all
skin types (I-VI). The CoolRoller™ is an accessory
providing pre-cooling of the skin, reduction in
thermal injury, and reduction in pain and patient
discomfort.
16

ko2ouS 3 2/2.
Intended Use of the Device:
The EsteLux™ System is intended for permanent
hair reduction, effective removal of unwanted hair,
treatment of facial and leg veins, and treatment of
pigmented lesions in all skin types (I-VI). The Cool
Roller™ is an accessory providing pre-cooling of
the skin and increased patient comfort.
Performance Data:
The differences in the specifications of the
EsteLux™ and CoolRoller™, and the predicate
devices do not result in different performance or
taise new questions of safety or efficacy.
Conclusion:
Based on the foregoing, the EsteLux™ System and
the CoolRoller™ are substantially equivalent to the
legally-marketed claimed predicate devices, i.e., the
ESC IPL™ Quantum HR and Laserscope
CoolSpot™, respectively.
17

mma
f &¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
% eo
“en Food and Drug Administration
. 9200 Corporate Boulevard
MAY 10-2002 Rockville MD 20850
; Palomar Medical Technologies, Inc. .
c/o Ms. Marcy Moore
: Manager of Clinical Studies :
131 Kelekent Lane ,
Cary, NC 27511 .
Re: K020453
Trade/Device Name: EsteLux™ Pulsed Light System and CoolRoller™
Regulation Number: 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: February 8, 2002
Received: February 11, 2002
Dear Ms. Moore: ~
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Ms. Marcy Moore
_ This letter will allow you to begin marketing your device as described in your Section 510(k)

| premarket notification: The FDA finding of substantial equivalence of your device to a legally .

: marketed predicate device results in a classification for your device and thus, permits your device |
to proceed to the market. |
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and |
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of |
Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of |
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the |
regulation entitled, "Misbranding by reference to premarket notification” (21CFR Part 807.97).

Other general information on your responsibilities under the Act may be obtained from the
Division of Small Manufacturers, International and Consumer Assistance at its toll-free number :
(800) 638-2041 or (301) 443-6597 or at its Internet address
http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
fo catia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
: Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

/ ; INDICATIONS FOR USE STATEMENT . :
500K) Number: “K020453 _ ,
Device Name: EsteLux™ :
Indications for Use:
The EsteLux™ Pulsed Light system is intended to for permanent
hair reduction. It is also indicated for photocoagulation of
dermatological vascular lesions, photothermolysis of blood vessels
(treatment of facial and leg veins), and the treatment of benign
pigmented lesions.
The CoolRoller™ is intended to provide pre-cooling of the
epidermis, to reduce thermal injury to the epidermis, and to reduce
pain and patient discomfort associated with light applications.
(Please do not write below this line - Continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use K OR Over-the-Counter Use
(per 21 CFR 801.109)
Yaicand 6 flovrat—_
(Division Sign-Off) .
Division of General, Restorative
and Neurological Devices
510(k) Number == 020 75-3 9

